Trials
Search / Trial NCT06429020

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Launched by CHIMEI MEDICAL CENTER · May 20, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Completed

Keywords

Breast Neoplasms Covid 19 Vaccine Lymphadenopathy

ClinConnect Summary

Study Design and Sample The retrospective study included female patients who underwent breast sonography in the radiology department of Chi Mei Medical Center between July 2021 and March 2022. The patients' breast cancer history and COVID-19 vaccination history were collected and analyzed.

Analysis of Breast Sonography Lymphadenopathy is defined as an enlarged lymph node with cortical thickening \>3 mm, either concentric or eccentric, with or without effacement of fatty hilum, or in-creased non-hilar vascularity on color or power Doppler. The positive axillary lymph node findings were corr...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • female patients receiving breast sonography
  • Exclusion Criteria:
  • • receive Covid 19 vaccine other than AZ, BNT, Moderna
  • • Ongoing primary breast malignancy
  • • History of malignancy other than primary breast malignancy

Trial Officials

Pin Chi Huang

Study Chair

ChiMei Medical Center, Taiwan, R.O.C.

About Chimei Medical Center

Chimei Medical Center is a leading healthcare institution in Taiwan, recognized for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure and a multidisciplinary team of experts, the center conducts a wide range of clinical studies across various therapeutic areas, focusing on the development of novel treatments and interventions. Chimei Medical Center is dedicated to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Through its collaborative approach, the center aims to foster advancements in healthcare and enhance patient outcomes.

Locations

Tainan City, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0